Centerspace
NYSE:CSRREIT - Residential
-$0.16 today
- Market cap
- $944.16M
- Beta
- 0.89
- P/E (TTM)
- 110.2
- EPS (TTM)
- $0.50
- Dividend yield
- 5.63%
Volume 0.16M
Average 0.15M
CSR Sales of Investments
Cash received from selling or redeeming investments.
CenterspaceNYSE: CSR
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments outflow grows to $0
Q1 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $132.7M. Over 3 fiscal years it compounded at +1379.4% a year.
Context
- Sales of investments amounted to 37.6% of revenue in FY2025, up 30.4 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $33.18M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 132.77M USD
- Year-over-year change
- +605.1%
- 4-year CAGR
- +40.8%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 132.77M | +605.1% |
| FY2024 | 2024-12-31 | 18.83M | -91.6% |
| FY2023 | 2023-12-31 | 223.26M | +544434.1% |
| FY2022 | 2022-12-31 | 41K | -99.9% |
| FY2021 | 2021-12-31 | 33.82M | — |
Sales of Investments vs competitors
How CSR compares with its peers on the latest reported figures
- CSR's LTM Mar 2026 sales of investments of $132.7M is the 3rd largest of the 9 companies compared; the peer median is $0.
- Its year-over-year change of +8216.5% is the highest of 6, against a peer median of -89.8%.
- Sales of investments amounts to 48.9% of revenue for CSR, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.32B | +116.9% | -18.2% | 94.0% | |
| LTM Mar 2026 | $485.99M | -89.8% | +4.9% | 63.5% | |
| LTM Mar 2026 | $132.7M | +8216.5% | +1379.4% | 48.9% | |
| LTM Mar 2026 | $23.1M | +234.6% | — | 7.9% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CSR) | $0 | -89.8% | -6.7% | 0.0% | |
Competitors are the stored peer set for CSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.1M) | (17.64M) | 41.97M | (14.19M) | (2.41M) |
| Depreciation & Amortization | 93.11M | 106.21M | 103.17M | 107.65M | 116.57M |
| Deferred Income Tax | (24.68M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.69M | 2.62M | 3.3M | 3.01M | 3.45M |
| Change in Working Capital | 10.35M | 5K | (2.87M) | (3.46M) | (5.37M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 15.75M | 650K | (2.11M) | 1.44M | 245K |
| Other Working Capital | (5.4M) | (645K) | (760K) | (4.9M) | (5.62M) |
| Other Non-Cash Items | 4.66M | 804K | (56.04M) | 5.23M | (13.78M) |
| Operating Cash Flow | 84.03M | 91.99M | 89.52M | 98.25M | 98.45M |
| Capital Expenditures | (35.88M) | (56.57M) | (58.83M) | (56.65M) | (34.16M) |
| Acquisitions (Net) | 328.06M | 161.32M | 0 | 0 | 0 |
| Purchases of Investments | (292.18M) | (104.67M) | 0 | 0 | 0 |
| Sales of Investments | 33.82M | 41K | 223.26M | 18.83M | 132.77M |
| Other Investing Activities | (301.04M) | (160.09M) | 120.21M | (69.54M) | (159.63M) |
| Investing Cash Flow | (267.23M) | (160.09M) | 120.21M | (50.72M) | (26.87M) |
| Debt Repayment | 113.12M | 108.07M | (140.25M) | 6.5M | 10.79M |
| Common Stock Issued | 156.04M | 31.44M | 0 | 112.07M | 0 |
| Common Stock Repurchased | 0 | (33.2M) | (11.58M) | (4.7M) | (4.63M) |
| Dividends Paid | (45.56M) | (51.53M) | (50.81M) | (51.25M) | (51.56M) |
| Other Financing Activities | (9.09M) | (13.41M) | (9.72M) | (9.25M) | (23.66M) |
| Financing Cash Flow | 214.51M | 41.37M | (212.35M) | (43.67M) | (69.06M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 31.32M | (26.73M) | (2.62M) | 3.86M | 2.52M |
| Free Cash Flow | 48.15M | 35.42M | 30.7M | 41.59M | 64.29M |
Centerspace
NYSE:CSR
Intrinsic Alpha fair value
Locked
Current Price
$56.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.